Daraxonrasib Chemotherapy Combination Shows Promising Tumour Shrinkage in Metastatic Pancreatic Cancer Trial
A phase I/II clinical trial found that combining daraxonrasib with standard chemotherapy induced substantial tumour shrinkage and prolonged disease control ...


